SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-039476
Filing Date
2012-07-13
Accepted
2012-07-13 18:47:52
Documents
1
Period of Report
2012-07-13

Document Format Files

Seq Description Document Type Size
1 form451937_20120713064716-.html 4  
1 form451937_20120713064716-.xml 4 17015
  Complete submission text file 0001144204-12-039476.txt   18504
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 12962545